US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street JournalT
TXMD
Therapeuticsmd Inc
1.11
0.02+1.83%After Hours: 1.160 +0.050 +4.50%18:42 12/20 EST
OPEN/PREV CLOSE1.100/1.090
TODAY RANGE1.080-1.160
VOL40.45K
MARKET CAP12.80M
52 WEEK RANGE1.050-2.750
AVG VOL (3M)18.16K
% TURNOVER0.35%
TURNOVER--
P/E (TTM)-3.8157
% RANGE5.51%
EPS(TTM)-0.2909
P/E(FORWARD)-2.9211
P/B0.4724
BVPS2.350
DIVIDEND--
P/S9.83
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP12.58M
SHARES OUTSTANDING11.53M
NEXT EARNINGS03/27-03/31
FREE FLOAT11.34M
LOT SIZE1
EX-DIV DATE05/09/2022
News
Press Releases
Financial Reports
Profile
TipRanks·11/13 04:48
TherapeuticsMD Reports Reduced Losses Amid Strategic Shift
Seeking Alpha·11/12 23:14
Therapeutics MD GAAP EPS of -$0.05
TipRanks·11/12 22:04
TherapeuticsMD Shifts Focus with Lower Q3 Losses
Reuters·11/12 21:05
THERAPEUTICSMD INC: QTRLY SHR LOSS FROM CONT OPS $0.05
Dow Jones·11/12 21:05
Press Release: TherapeuticsMD Announces Third Quarter 2024 Financial Results
Benzinga·08/26 11:36
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
Investorplace·08/13 01:55
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024
Press release·08/12 23:45
TherapeuticsMD, Inc. Reports Financial Results for the Quarter Ended June 30, 2024
Seeking Alpha·08/12 21:07
Therapeutics MD GAAP EPS of -$0.09
TipRanks·08/12 20:31
TherapeuticsMD Releases Preliminary Quarterly Financial Results
Dow Jones·08/12 20:10
*TherapeuticsMD 2Q License Rev $234,000
Reuters·08/12 20:05
THERAPEUTICSMD INC: QTRLY EPS LOSS FROM CONT OPS $0.09
Seeking Alpha·05/30 20:55
Nektar, Verastem among healthcare additions in Russell Microcap; Assertio, Sangamo removed
Press release·05/11 08:33
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Investorplace·05/11 00:53
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024
Same Industry
Name/Symbol
Change%
Price